|
|

 |
In this recording of a live Web Workshop, Margaret Lester, RN, MSN, FNP,
AE-C, uses a problem-based learning approach to present a real-life case
scenario. As the details of the case unfolds, you have the chance to share your
expertise. Listen as your colleagues interact with the presenter and discuss the best evidence-based therapies for this patient. A question and answer session follows the presentation.
Recorded Live: Tuesday, September 12, 2006
[View Recording] |
|
|
Overview
Listen as your colleagues interact with the presenter and discuss the best evidence-based therapies for this patient. A question and answer session follows the presentation. |
| |
|
|
Learning Objectives
Upon completion of this course, you should be able to:
-
Analyze data from a patient’s history, physical examination, and diagnostic testing to make an accurate diagnosis in a patient with airway obstruction
-
Stage the patient’s disease by using accepted guidelines
-
Appropriately select evidence-based treatment options
|
|
| Target Audience |
| The CE activity is designed for nurse practitioners and other healthcare providers who manage patients with chronic obstructive pulmonary disease. |
|
|
Learner Participation to Earn Credit |
| |
|
| Faculty Disclosures |
 |
| Margaret Lester, RN, MSN, FNP, AE-C
[BioSketch]
|
| Family Nurse Practitioner and Certified Asthma Educator |
| Disclosure: Consultant/Speaker: GlaxoSmithKline, Altana/Pfizer; Speaker: Boehringer Ingelheim |
|
|
 |
| Wendy Wright, MS, RN, ARNP, FNP
[BioSketch]
|
| Family Nurse Practitioner |
| Disclosure: Speaker's Bureau: Pfizer, GSK, Roche, AstraZeneca, Exact Sciences, KOS; Grants: GSK, Roche, AstraZeneca, Exact Sciences |
|
|
|
|
| Conflict of Interest/Disclosure Statement |
|
As a provider of accredited CE/CME activities, MEBN must ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All faculty participating in these activities are expected to disclose any or no relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of any or no relationship(s) will be listed prior to any educational activity.
All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.
|
|
| Accreditation Statement |
| |
|
Continuing Medical Education for Nurse Practitioners
This program has been approved for 1 contact hour(s) of continuing education (which includes .3 hours of pharmacology) by the American Academy of Nurse Practitioners, Program ID 0603095. This program is eligible for contact hours through May 31, 2008.
|
|
|
|
Disclaimer This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.
|
|
|
|
|
Course Certificate Fees
This course is FREE to all healthcare professionals. |
|
|
|
|
|